197 related articles for article (PubMed ID: 118839)
1. Binding of serum amyloid P-component (SAP) by amyloid fibrils.
Pepys MB; Dyck RF; de Beer FC; Skinner M; Cohen AS
Clin Exp Immunol; 1979 Nov; 38(2):284-93. PubMed ID: 118839
[TBL] [Abstract][Full Text] [Related]
2. Agglutination of complement-coated erythrocytes by serum amyloid P-component.
Hutchcraft CL; Gewurz H; Hansen B; Dyck RF; Pepys MB
J Immunol; 1981 Mar; 126(3):1217-9. PubMed ID: 7462631
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat.
de Beer FC; Baltz ML; Munn EA; Feinstein A; Taylor J; Bruton C; Clamp JR; Pepys MB
Immunology; 1982 Jan; 45(1):55-70. PubMed ID: 7056568
[TBL] [Abstract][Full Text] [Related]
4. Binding of human serum amyloid P-component to phosphocholine.
Christner RB; Mortensen RF
Arch Biochem Biophys; 1994 Nov; 314(2):337-43. PubMed ID: 7979374
[TBL] [Abstract][Full Text] [Related]
5. Receptor-ligand interactions between serum amyloid P component and model soluble immune complexes.
Brown MR; Anderson BE
J Immunol; 1993 Aug; 151(4):2087-95. PubMed ID: 8393897
[TBL] [Abstract][Full Text] [Related]
6. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
Harris DL; King E; Ramsland PA; Edmundson AB
J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
[TBL] [Abstract][Full Text] [Related]
7. Role of STAT3 and C/EBP in cytokine-dependent expression of the mouse serum amyloid P-component (SAP) and C-reactive protein (CRP) genes.
Ochrietor JD; Harrison KA; Zahedi K; Mortensen RF
Cytokine; 2000 Jul; 12(7):888-99. PubMed ID: 10880233
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid P component forms a stable complex with human C5b6.
Barbashov SF; Wang C; Nicholson-Weller A
J Immunol; 1997 Apr; 158(8):3830-5. PubMed ID: 9103450
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.
Hohenester E; Hutchinson WL; Pepys MB; Wood SP
J Mol Biol; 1997 Jun; 269(4):570-8. PubMed ID: 9217261
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
Pepys MB
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
[TBL] [Abstract][Full Text] [Related]
11. [Amyloid P components in normal human skin and skin with lesions].
Hintner H; Breathnach SM
Hautarzt; 1988 Nov; 39(11):712-6. PubMed ID: 3072321
[TBL] [Abstract][Full Text] [Related]
12. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
Ying SC; Gewurz AT; Jiang H; Gewurz H
J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
[TBL] [Abstract][Full Text] [Related]
13. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
Maeda S
Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
[TBL] [Abstract][Full Text] [Related]
14. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.
Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB
Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204
[TBL] [Abstract][Full Text] [Related]
15. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.
García de Frutos P; Dahlbäck B
J Immunol; 1994 Mar; 152(5):2430-7. PubMed ID: 8133054
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages.
Bijl M; Horst G; Bijzet J; Bootsma H; Limburg PC; Kallenberg CG
Arthritis Rheum; 2003 Jan; 48(1):248-54. PubMed ID: 12528126
[TBL] [Abstract][Full Text] [Related]
17. Amino terminal sequence of amyloid P-component isolated from serum.
Benson MD; Skinner M
J Lab Clin Med; 1978 Jul; 92(1):78-83. PubMed ID: 96197
[TBL] [Abstract][Full Text] [Related]
18. Isolation of serum amyloid P-component (protein SAP) in the mouse.
Pepys MB
Immunology; 1979 Jul; 37(3):637-41. PubMed ID: 500121
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein.
Li XA; Yutani C; Shimokado K
Biochem Biophys Res Commun; 1998 Mar; 244(1):249-52. PubMed ID: 9514915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
